ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Escalating Waitlist Mortality Above MELD 40: A Rationale to Uncap MELD 3.0?

A. Kwong, A. Mannalithara, W. Kim

Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA

Meeting: 2022 American Transplant Congress

Abstract number: 1106

Keywords: Allocation, Liver cirrhosis, Liver transplantation, Waiting lists

Topic: Clinical Science » Liver » 60 - Liver: MELD Allocation*

Session Information

Session Name: Liver: MELD Allocation*

Session Type: Poster Abstract

Date: Sunday, June 5, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

Session Information

Session Name: Poster Chat: Liver

Session Type: Poster Chat

Date: Tuesday, June 7, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Hall C

*Purpose: MELD 3.0 is a recently proposed model that improves upon MELD-Na, incorporating sex and albumin as additional variables, updating existing coefficients and adding relevant interactions, and resetting the upper bound of serum creatinine to 3.0 from 4.0 mg/dL. Conventionally, MELD is capped at 40 in the liver allocation system, and waitlist priority in case of ties is then ordered by waiting time. This study evaluates the impact of MELD-Na and MELD 3.0 scores beyond this threshold on waitlist mortality among liver transplant candidates.

*Methods: New adult waitlist registrations for liver transplantation from January 15, 2016 to June 30, 2021 were identified using OPTN data. MELD-Na, and MELD 3.0 scores from registration were calculated, and differences in waitlist and post-transplant mortality by MELD strata 40, 41-45, 46-49, and 50+ were assessed.

*Results: There were 68,086 new waitlist registrations for liver transplantation during the study period, 3213 (4.7%) with MELD-Na ≥40 and 3875 (5.2%) with MELD 3.0 ≥40. Short-term waitlist mortality was higher for each increasing MELD 3.0 stratum, from 52.6% at 30 days to 90.5% at 30 days for those with MELD 40 compared to MELD >50 (Table). One-year post-transplant outcomes were comparable across MELD strata.

*Conclusions: MELD 3.0 is anticipated to increase the proportion of patients reaching or surpassing the maximum allocation score of 40. Patients with MELD >40 may derive greater survival benefit from LT compared to MELD 40. Uncapping MELD 3.0 improves risk stratification of waitlist mortality and better represents urgency for liver transplant for the sickest patients including those with acute-on-chronic liver failure.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Kwong A, Mannalithara A, Kim W. Escalating Waitlist Mortality Above MELD 40: A Rationale to Uncap MELD 3.0? [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/escalating-waitlist-mortality-above-meld-40-a-rationale-to-uncap-meld-3-0/. Accessed May 25, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences